Business
Eurobio Scientific: 2024 annual results
2024 ANNUAL RESULTS Growth of core business and strategic execution Revenue up 19% to €154 million Organic growth at +9%Proprietary products account for a stable 31% of group revenueInternational accounts for 41% of group revenue Stable 2024 operational results, reflecting pressure on margins and underperformance of some European subsidiariesFree cash flow of €6 millionNet debt of €3.9 million, including EB Development current account Paris, April 28, 2024 - 5:40 pm - Eurobio Scientific (FR00132
About this update from Eurobio-scientific Sa
[{"type":"image","alt":"Eurobio Scientific","displaySize":"","headline":null,"caption":"Eurobio Scientific","className":"","disableSlideshowImg":false,"size":{"original":{"width":250,"height":71,"url":"https://media.zenfs.com/en/globenewswire.com/f9faa06825e5acb815281cbc2a20a33c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/m45eRi4SxGSzLe.1oTz.Qw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTExOTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/f9faa06825e5acb815281cbc2a20a33c","width":250,"height":71}},"lazy":false},{"type":"text","content":"2024 ANNUAL RESULTS ","length":19,"tagName":"p"},{"type":"text","content":"Growth of core business and strategic execution","length":47,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue up 19% to €154 million","length":30,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Organic growth at +9%","length":21,"tagName":"p"}]},{"val":[{"type":"text","content":"Proprietary products account for a stable 31% of group revenue","length":62,"tagName":"p"}]},{"val":[{"type":"text","content":"International accounts for 41% of group revenue","length":47,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":130,"olType":false}]},{"val":[{"type":"text","content":"Stable 2024 operational results, reflecting pressure on margins and underperformance of some European subsidiaries","length":114,"tagName":"p"}]},{"val":[{"type":"text","content":"Free cash flow of €6 million","length":28,"tagName":"p"}]},{"val":[{"type":"text","content":"Net debt of €3.9 million, including EB Development current account","length":66,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":368,"olType":false},{"type":"text","content":"Paris, April 28, 2024 - 5:40 pm - Eurobio Scientific (FR0013240934, ALERS, PEA-PME eligible), a leading French group in in vitro medical diagnostics and life sciences, today presents its consolidated annual results for 2024, prepared under French GAAP and approved by the company's Board of Directors, which met on April 28, 2025.","length":334,"tagName":"p"},{"type":"text","content":"Eurobio Scientific's annual results for 2024 reflect both the Group's ability to grow in its core markets, and the increasing pressure on margins, as well as the difficulties encountered by some European subsidiaries.","length":225,"tagName":"p"},{"type":"table","hea...